These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14306915)

  • 41. Gels and other topical corticosteroids.
    Med Lett Drugs Ther; 1974 Jun; 16(12):50-2. PubMed ID: 4831241
    [No Abstract]   [Full Text] [Related]  

  • 42. THE THYMOLYTIC ACTIVITY OF 6- AND 9-HALOCORTICOIDS AND RELATED STEROIDS.
    DORFMAN RI; HOLTON PG; KINCL FA
    Acta Endocrinol (Copenh); 1965 Jun; 49():262-70. PubMed ID: 14303255
    [No Abstract]   [Full Text] [Related]  

  • 43. The activity of fluocinonide on diseases and healthy skin in comparison with other topical corticosteroids.
    Kalkoff KW
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):51-6. PubMed ID: 5291633
    [No Abstract]   [Full Text] [Related]  

  • 44. [PHARMACOLOGY OF SYNTHETIC CORTICAL STEROIDS OF ANTIINFLAMMATORY ACTION].
    GIJON JR; RODRIGUEZMURCIA C; ALIADIAZ M
    An Real Acad Farm; 1963; 29():361-90. PubMed ID: 14122037
    [No Abstract]   [Full Text] [Related]  

  • 45. Characterization of Transcriptomic and Proteomic Changes in the Skin after Chronic Fluocinolone Acetonide Treatment.
    Choi Y; Takasugi M; Takemura K; Yoshida Y; Kamiya T; Adachi J; Tsuruta D; Ohtani N
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [EXPERIENCES WITH THE LOCAL CORTICOSTEROID, FLUOCINOLONE ACETONIDE].
    SCHNYDER UW
    Schweiz Med Wochenschr; 1964 Dec; 94():1762-5. PubMed ID: 14335017
    [No Abstract]   [Full Text] [Related]  

  • 47. [Comparative evaluation of the therapeutic effectiveness of different topical corticosteroid preparations in certain dermatoses].
    Kolokolova NV; Boglaeva VM; Fedorova GA; Orlova KE; Chernova TD
    Vestn Dermatol Venerol; 1970 Aug; 44(8):32-5. PubMed ID: 4250230
    [No Abstract]   [Full Text] [Related]  

  • 48. CURRENT CONCEPTS IN THE DIAGNOSIS AND TREATMENT OF PSORIASIS.
    FARBER EM; ROTH RJ
    GP; 1964 Jun; 29():94-9. PubMed ID: 14143830
    [No Abstract]   [Full Text] [Related]  

  • 49. Topical corticosteroids for skin disorders.
    Med Lett Drugs Ther; 1966 May; 8(10):37-8. PubMed ID: 4223426
    [No Abstract]   [Full Text] [Related]  

  • 50. Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent.
    Medansky RS; Bressinck R; Cole GW; Deeken JH; Ellis CN; Guin JD; Herndon JH; Lasser AE; Leibsohn E; Menter MA
    Cutis; 1988 Nov; 42(5):480-5. PubMed ID: 3058398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [OUR OBSERVATIONS WITH THE TOPICAL USE OF FLUOCINOLONE ACETONIDE].
    GATTI JC; CARDAMA JE; BALINA LM
    Dia Med; 1963 Sep; 35():1509. PubMed ID: 14092144
    [No Abstract]   [Full Text] [Related]  

  • 52. Corticosteroid-induced cutaneous atrophy and telangiectasia. Experimental production associated with weight loss in rats.
    Smith JG; Wehr RF; Chalker DK
    Arch Dermatol; 1976 Aug; 112(8):1115-7. PubMed ID: 952530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Results of treatment of various skin diseases with fluocinolone acetonide cream].
    ABE T; HATTORI N; SUGANO H
    Hifuka Kiyo; 1962 May; 57():221-3. PubMed ID: 14010616
    [No Abstract]   [Full Text] [Related]  

  • 54. [Corticosteroid effect and vasoconstriction. 1. Suppression of corticosteroid-induced vasoconstriction in the healthy skin by tolazoline].
    Brehm K; Maucher OM
    Arzneimittelforschung; 1972 Jun; 22(6):1038-9. PubMed ID: 5068352
    [No Abstract]   [Full Text] [Related]  

  • 55. [COMPARATIVE STUDIES ON EXTERNAL CORTICOSTEROIDS. THE PRO AND CON OF THE ANTIBIOTIC ADDITIVE].
    SIMONS RD
    Hautarzt; 1964 Jun; 15():287-94. PubMed ID: 14234732
    [No Abstract]   [Full Text] [Related]  

  • 56. [PSORIASIS: TOPICAL TREATMENT WITH FLUOCINOLONE ACETONIDE].
    PORTO JA
    Hospital (Rio J); 1963 Jul; 64():95-9. PubMed ID: 14054351
    [No Abstract]   [Full Text] [Related]  

  • 57. Inhibition of contact sensitivity in the mouse by topical application of corticosteroids.
    Evans DP; Hossack M; Thomson DS
    Br J Pharmacol; 1971 Oct; 43(2):403-8. PubMed ID: 5158205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Response of psoriatic lesions to topical fluocinolone acetonide.
    TYE MJ; SCHIFF BL; ANSELL HB
    Arch Dermatol; 1963 Jan; 87():27-31. PubMed ID: 13995018
    [No Abstract]   [Full Text] [Related]  

  • 59. [COMPARATIVE STUDIES ON THE TOPICAL TREATMENT OF ECZEMA WITH FLUOCINOLONE ACETONIDE AND 6-ALPHA-METHYLPREDNISOLONE ACETATE].
    BJOERNBERG A; HELLGREN L; MARTIN B
    Dermatol Wochenschr; 1964 Jul; 150():12-3. PubMed ID: 14252713
    [No Abstract]   [Full Text] [Related]  

  • 60. TREATMENT OF RADIATION DERMATITIS WITH FLUOCINOLONE ACETONIDE.
    BJOERNBERG A; HELLGREN L; OLSSON S
    Acta Radiol Ther Phys Biol; 1965 Apr; 3():129-34. PubMed ID: 14298788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.